U.S. Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), and Segment Forecasts, 2024-2030

The U.S. intravenous solutions market size is anticipated to reach USD 7.90 billion by 2030 and is projected to grow at a CAGR of 7.8% from 2024 to 2030. The market growth is observed due to the rising prevalence of diseases, and the increasing number of surgeries. In addition, the rising number of geriatric population susceptible to non-communicable diseases such as cancer, neurological disorders, cardiovascular disorders, and spinal injuries is likely to impact market growth.

The increasing number of hospitals, ambulatory surgical centers, intravenous (IV) solutions infusion centers, and med spas contribute to the market growth. According to the data published by the Ambulatory Surgery Center Association, the number of ambulatory surgery centers in the U.S. in 2022 was 6087, out of which California state had the highest number (848), followed by Florida state (468).

IV hydration therapy is a highly effective treatment for severe dehydration. Individuals with certain chronic illnesses, such as diabetes or certain kidney conditions, may be at a greater risk of dehydration. Rehydration therapy helps to restore the proper electrolyte balance in the body. The most commonly used IV treatment is a simple saline solution that contains water and sodium chloride. However, solutions containing sugar, such as glucose, dextrose, or levulose, are also frequently used. For instance, in December 2023, Baxter, a prominent figure in infusion therapies and technologies, completed the initial phase of its pilot program for IV bag recycling with Northwestern Medicine. This effort has diverted over six tons of PVC IV bag waste from landfills. This amount could stretch across Chicago if laid end-to-end, promoting environmentally sustainable reuse.

U.S. Intravenous Solutions Market Report Highlights

• Based on type, the total parenteral nutrition segment led the market with the largest revenue share of 67.02% in 2023, owing to the increased number of chronic disorders and the surgeries need to treat them
• Based on nutrients, the vitamins and minerals (salt and electrolyte) segment is expected to grow at the fastest CAGR of 10.0% over the forecast period
• Based on nutrients, The single dose amino acids segment led the market with the largest revenue share 31.27% in 2023
• In September 2020, Baxter got the U.S. FDA approval to develop new formulations of its product Clinimix to provide more protein while delivering less dextrose